Android app on Google Play

Piper Jaffray Starts Corcept Therapeutics (CORT) at Overweight

January 3, 2013 4:59 PM EST Send to a Friend
Get Alerts CORT Hot Sheet
Price: $2.76 --0%

Rating Summary:
    5 Buy, 5 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade CORT Now!
Join SI Premium – FREE
Piper Jaffray initiates coverage on Corcept Therapeutics (NASDAQ: CORT) with a Overweight. PT $4.00.

For an analyst ratings summary and ratings history on Corcept Therapeutics click here. For more ratings news on Corcept Therapeutics click here.

Shares of Corcept Therapeutics closed at $1.48 yesterday.




You May Also Be Interested In


Related Categories

New Coverage

Related Entities

Piper Jaffray

Add Your Comment